APAC

Its expansion is attributed to developments in IOS technology.

The growing geriatric population is contributing to the increasing demand.

Large and medium-sized companies view this as a greater concern compared to smaller enterprises.

It is driven by developments in personalised medicine, gene therapy, and CRISPR technology.

High cost is a major challenge.

The increase has been faster in women since 2000.

It will be driven by the rising prevalence of cancer.

Key drivers include chronic conditions and an ageing population.

Its expansion is attributed to developments in healthcare infrastructure.

The trade show, which was held in Singapore, successfully brought together over 13,000 visionary digital health innovators, government leaders, and industry pioneers from the medical and healthcare sectors.

There are a total of 93 products in Phase I-III development for PD treatment.

Recruitment and retention pose a major concern for organisations.

It is due to an increased focus on maximising dental chair utilisation.

Its expansion is driven by an ageing population and the rising rates of chronic diseases.

The partnership includes local testing of clinical AI projects developed by Apollo.

This is due to the increasing prevalence of CVD and metabolic disorders.